New oral drug trial offers hope for advanced prostate cancer patients
NCT ID NCT06155084
Summary
This early-stage study is testing a new oral medication called HP518 for men with advanced prostate cancer that has spread and stopped responding to standard treatments. The trial aims to find the safest and most effective dose while checking if the drug can reduce cancer markers and control tumor growth. It involves 84 patients in China who have already tried other treatments without success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, China
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
Contact
-
Lanzhou University Second Hospital
RECRUITINGLanzhou, Gansu, China
Contact
-
Liaoning Cancer Hospital & Institute
RECRUITINGShenyang, Liaoning, China
Contact
-
Mianyang Central Hospital
RECRUITINGMianyang, Sichuan, China
Contact
-
Shandong Provincial Hospital
RECRUITINGJinan, Shandong, China
Contact
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Contact
-
Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, China
Contact
-
The Affiliated Hospital Of Guizhou Medical University
RECRUITINGGuiyang, Guizhou, China
Contact
-
The Affiliated Hospital Of Qingdao University
RECRUITINGQingdao, Shandong, China
Contact
-
The Affiliated Hospital Of School Of Medicine Of Ningbo University
RECRUITINGNingbo, Zhejiang, China
Contact
-
The Affiliated Hospital Of Southwest Medical University
RECRUITINGLuzhou, Sichuan, China
Contact
-
The First Affiliated Hospital Of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Contact
-
The First Affiliated Hospital Of Xi'An Jiaotong Univeristy
RECRUITINGXi’an, Shanxi, China
Contact
-
The First Affiliated Hospital Of Xiamen Univeristy
NOT_YET_RECRUITINGXiamen, Fujian, China
Contact
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, China
Contact
-
The Second Affiliated Hospital Of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, China
Contact
Contact
-
The Second Affiliated Hospital Of Kunming Medical University
RECRUITINGKunming, Yunnan, China
Contact
-
The Second Hospital Of Anhui Medical University
RECRUITINGHefei, Anhui, China
Contact
-
The Third Affiliated Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, China
Contact
-
Tongji Hospital
RECRUITINGWuhan, Hubei, China
Contact
-
West China Hospital Of Sichuan University
RECRUITINGChengdu, Sichuan, China
Contact
Contact
-
Yantai Yuhuangding Hospital
RECRUITINGYantai, Shandong, China
Contact
-
Zhengzhou Central Hospital
RECRUITINGZhengzhou, Henan, China
Contact
Conditions
Explore the condition pages connected to this study.